Bone morphogenetic protein4 (BMP4) treatment caused a substantial rise in PTEN levels in conjunction with the induction of differentiation and loss of tumorigenicity in CRC stem cells, but was not effective in stem cells harboring a PI3KCA mutation or with complete PTEN loss (Lombardo et al., 2011). Here, PTEN is linked to colorectal carcinoma.